2,064 results on '"Mannucci, Pier Mannuccio"'
Search Results
2. Drug prescription appropriateness in hospitalized older patients: 15-year results and lessons from a countrywide register
3. Environmental health and clinicians: time to promote more action
4. Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study
5. A European National Health and Social Service model: the S of social
6. Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study
7. Post-recovery impact of the second and third SARS-CoV-2 infection waves on healthcare resource utilization in Lombardy, Italy
8. A European national health and social service model: imagining a rational philosophy for health care organizations
9. A European national health and social service model: a rational network of health care facilities
10. Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy
11. Hemophilia patients: are they naturally anticoagulated?
12. Rare inherited coagulation disorders: no longer orphan and neglected
13. Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact
14. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both
15. The role of general practitioners in the EU: time to draw lessons from a too wide range?
16. A European national health and social service model: a few rules of the game
17. Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients
18. Low serum albumin is associated with mortality and arterial and venous ischemic events in acutely ill medical patients. Results of a retrospective observational study
19. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
20. Hemophilia treatment innovation: 50 years of progress and more to come
21. Why so many different specialty training programmes in general practice in Europe?
22. Pharmaceutical pricing in Europe: time to take the right direction
23. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
24. Association between air temperature, air pollution and hospital admissions for pulmonary embolism and venous thrombosis in Italy
25. Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
26. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
27. Integrated care: easy in theory, harder in practice?
28. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients
29. RARE INHERITED COAGULATION DISORDERS (RICD): NO LONGER ORPHAN AND NEGLECTED
30. Pharmaceutical patenting in the European Union: reform or riddance
31. Perspective – The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021
32. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
33. Von Willebrand disease type 2N: An update
34. Pharmacist-driven medication recognition/ reconciliation in older medical patients
35. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge
36. Improving primary care in Europe beyond COVID-19: from telemedicine to organizational reforms
37. Tranexamic Acid: An Evergreen Hemostatic Agent.
38. Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect.
39. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study
40. Low‐dose emicizumab for more equitable access to prophylaxis in resource limited countries
41. Factor VIII and von Willebrand factor are wavering proteins: the basis for the therapeutic development of desmopressin
42. Efficacy and safety of tranexamic acid in acute haemorrhage
43. Association Between Long-Term Exposure to Air Pollution and Incidence of Peripheral Artery Disease Evidence from the Rome Longitudinal Study
44. Community and hospital pharmacists in Europe: encroaching on medicine?
45. A European National Health and Social Service model: the S of social
46. Antibiotic use and associated factors in a large sample of hospitalised older people
47. Potentially Inappropriate Medications, Drug–Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?
48. Pros and cons of the ISTH treatment guidelines for hemophilia
49. New therapies for von Willebrand disease
50. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.